Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
language:"Undetermined"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=language%3A%22Undetermined%22&lookfor=%22Immunoglobulins%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=language%3A%22Undetermined%22&lookfor=%22Immunoglobulins%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=language%3A%22Undetermined%22&lookfor=%22Immunoglobulins%22&type=Subject
PubPharm (11)
1
Dose response of IVIg in CIDP. : Dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Dose response of IVIg in CIDP. : Dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
ME/CFS – the Severely and Very Severely Affected
Erschienen: Basel,
MDPI - Multidisciplinary Digital Publishing Institute,
2023
von
Friedman, K.
|
Bateman, L.
|
De Meirleir, K.
Wird geladen...
4
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Sprache: Unbestimmt
Medienart
E-Ressourcen
10
Aufsätze
10
E-Artikel
1
Bücher
1
E-Books
Alle anzeigen ...
weniger ...
Zeitschriftentitel
10
WHO International Clinical Trials Registry Plat...
Thema
10
610
10
Study Type: Interventional
8
Phase: Phase 2
8
Recruitment Status: Authorised-recruitment may ...
6
Medical Condition: Lupus Nephritis (LN)Immunogl...
2
Medical Condition: Chronic inflammatory demyeli...
2
Medical Condition: Lupus Nephritis (LN) - Immun...
2
Recruitment Status: Completed
1
Adolescence
1
Adulthood
1
Apnea
1
Apnea-hypopnea index
1
Bedbound
1
Cardiac Function
1
Cardiopulmonary Exercise Testing
1
Caregivers
1
Case Study
1
Cerebral Blood Flow
1
Chronic Fatigue Syndrome
1
Clinical Presentation
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2023
2
2022
6
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Unbestimmt
Haven't found what you're looking for?
Wird geladen...